Nalaganje...
Dendritic Cells Pulsed with Exosomes in Combination with PD-1 Antibody Increase the Efficacy of Sorafenib in Hepatocellular Carcinoma Model()()
Advanced hepatocellular carcinoma (HCC) has limited therapeutic options. Immunotherapy is a promising treatment, while sorafenib is a first-line drug-based treatment for advanced HCC. However, the efficacy of sorafenib and immunotherapy in combination, have not been clearly evaluated. Sorafenib trea...
Shranjeno v:
| izdano v: | Transl Oncol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Neoplasia Press
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5789129/ https://ncbi.nlm.nih.gov/pubmed/29413757 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2018.01.001 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|